IONTAS
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
London Rd, Sawston, Cambridgeshire, CB22...Phone Number
+44 1223750801Website
www.iontas.co.ukRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About IONTAS
FairJourney Biologics specializes in providing end-to-end solutions for antibody research, including services such as antibody discovery, engineering, protein production, and cell line development. The company aims to support clients in achieving optimal antibody success through customized services and advanced technologies. Their intended clients include pharmaceutical and biotechnology companies seeking high-quality antibody solutions for therapeutic and diagnostic applications. With a team of experienced scientists, FairJourney Biologics is recognized for its speed, expertise, and comprehensive data delivery.Explore more
IONTAS Org Chart
ST
Health Safety & Laboratory Operations Head
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IONTAS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once IONTAS has new funding data
IONTAS, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at IONTAS
Product Launch: Get notified when IONTAS launches new products
Check out if IONTAS is spiking on competitors!
Check if IONTAS has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if IONTAS had a recent Job posting/layoffs
Earning: See what the market has to say on IONTAS recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to IONTAS
Compare insights from companies similar to IONTAS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
IONTAS is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
IONTAS is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about IONTAS.
IONTAS Tech Stack
A closer look at the technologies used by IONTAS
See more technologies
IONTAS News & Media
IONTAS Collaboration With F-star Enters Oncology Phase 1 Clinical Trial
CAMBRIDGE, England--(BUSINESS WIRE)--IONTAS Limited (IONTAS), a leader in the discovery and optimization of fully human antibodies, today announces that F-star Therapeutics, Inc. (NASDAQ: FSTX), has dosed the first patients in a Phase 1 clinical trial, with FS222, a CD137/PD-L1 bispecific antibody. IONTAS applied its proprietary technology to generate a component utilized within FS222, which was subsequently licenced to F-star. The initiation of this trial adds to the growing portfolio of antibFairJourney Biologics Enters Next-generation Antibody Discovery Collaboration With Argenx
PORTO, Portugal & CAMBRIDGE, England & LONDON--(BUSINESS WIRE)--FairJourney Biologics S.A (FJB) and IONTAS Limited (IONTAS), leaders in the discovery and optimisation of VHH fully human antibodies, today announced a collaboration with global immunology company, argenx to harness IONTAS’ proprietary mammalian display technology. The goal of the collaboration is to explore diverse panels of novel antibody candidates, with the potential to advance select candidates into the argenx discovery pipeliIONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies
CAMBRIDGE, England & PORTO, Portugal & LONDON--(BUSINESS WIRE)--IONTAS Limited (IONTAS) and FairJourney Biologics S.A (FJB)., leaders in the discovery and optimisation of fully human antibodies, have announced the identification of neutralizing antibodies, which bind to multiple emerging SARS-CoV-2 variants. The results, generated from a combination of phage display technology and B-cell receptor repertoire sequencing of hospitalized COVID-19 patients, have identified potent neutralizing antiboIONTAS and FairJourney Biologics Enter Antibody Discovery Agreement With Quell Therapeutics
CAMBRIDGE, England & PORTO, Portugal & LONDON--(BUSINESS WIRE)--IONTAS Limited (IONTAS) and FairJourney Biologics S.A (FJB)., leaders in the discovery and optimisation of fully human antibodies, have announced that they have entered into an agreement with Quell Therapeutics Limited (Quell) regarding IONTAS / FJB’s proprietary libraries and technology platforms. Quell is harnessing the suppressive capacity of Tregs to develop engineered Treg cell therapies to address several conditions of immune
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding IONTAS
Sign Up For FreeTo access detailed company insights
FairJourney Biologics specializes in providing end-to-end solutions for antibody research, including services such as antibody discovery, engineering, protein production, and cell line development. The company aims to support clients in achieving optimal antibody success through customized services and advanced technologies. Their intended clients... Read More
